Maria Berkman is a Partner at Vensana Capital. Maria brings over 20 years of venture, clinical,
and consulting experience to Vensana. Prior to Vensana, Maria was the Head of MedTech at
Broadview Ventures and Managing Director of Longview Ventures – affiliate funds dedicated to
early-stage investments in cardiovascular disease and stroke. Maria currently serves on the
boards of Alleviant Medical, AtaCor Medical, and Vectorious Medical Technologies, and
previously on the boards of Apama Medical (acquired), CardiAQ (acquired), Remedy
Therapeutics (acquired), Capricor Therapeutics (IPO), Lyra Therapeutics (IPO), CroíValve, XII
Medical, Puzzle Medical, and Relief Cardiovascular. Prior to her venture career, Maria was a
management consultant with Monitor Group and trained at Mass General Brigham’s Newton
Wellesley Hospital. She concurrently earned an MD from the UCLA School of Medicine and an
MBA from the Anderson School of Management at UCLA.